We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
+0.42%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+251.5%
AUM
$796M
AUM Growth
-$9.83M
Cap. Flow
-$8.19M
Cap. Flow %
-1.03%
Top 10 Hldgs %
21.92%
Holding
266
New
7
Increased
60
Reduced
128
Closed
11

Top Sells

Rank Stock Value
1
TDC icon
Teradata
TDC
+$1.77M
2
VZ icon
Verizon
VZ
+$1.14M
3
JNJ icon
Johnson & Johnson
JNJ
+$1.12M
4
AAPL icon
Apple
AAPL
+$996K
5
J icon
Jacobs Solutions
J
+$904K

Sector Composition

Rank Sector Weight
1 Healthcare 18.42%
2 Industrials 14.67%
3 Technology 12.65%
4 Consumer Staples 9.88%
5 Financials 6.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATR icon
26
AptarGroup
ATR
$8.7B
$8.55M 1.07%
134,094
-3,230
-2% -$206K
ECL icon
27
Ecolab
ECL
$78.6B
$8.5M 1.07%
75,160
+822
+1% +$94.5K
RTX icon
28
RTX Corp
RTX
$292B
$8.17M 1.03%
117,019
-6,206
-5% -$455K
DLTR icon
29
Dollar Tree
DLTR
$24.9B
$8.09M 1.02%
102,409
-1,983
-2% -$157K
MON
30
DELISTED
Monsanto Co
MON
$7.69M 0.97%
72,168
-1,825
-2% -$212K
AFL icon
31
Aflac
AFL
$64.5B
$7.41M 0.93%
238,154
-1,780
-0.7% -$56.3K
GLNG icon
32
Golar LNG
GLNG
$5B
$7.07M 0.89%
150,992
+244
+0.2% +$10.6K
FRC
33
DELISTED
First Republic Bank
FRC
$6.92M 0.87%
109,712
-1,360
-1% -$82.3K
TEVA icon
34
Teva Pharmaceuticals
TEVA
$40.2B
$6.52M 0.82%
110,391
-1,135
-1% -$70K
PX
35
DELISTED
Praxair Inc
PX
$6.5M 0.82%
54,398
-1,895
-3% -$231K
PH icon
36
Parker-Hannifin
PH
$126B
$6.46M 0.81%
55,499
-125
-0.2% -$15.1K
ABBV icon
37
AbbVie
ABBV
$433B
$6.27M 0.79%
93,362
-3,277
-3% -$214K
SYK icon
38
Stryker
SYK
$131B
$6.18M 0.78%
64,675
-1,375
-2% -$130K
MRK icon
39
Merck
MRK
$316B
$5.98M 0.75%
110,039
+2,148
+2% +$120K
DHR icon
40
Danaher
DHR
$139B
$5.96M 0.75%
103,663
-1,455
-1% -$83.3K
MMM icon
41
3M
MMM
$91.4B
$5.81M 0.73%
45,003
-1,686
-4% -$226K
VEU icon
42
Vanguard FTSE All-World ex-US ETF
VEU
$66.9B
$5.66M 0.71%
116,523
-2,691
-2% -$136K
WAB icon
43
Wabtec
WAB
$50.1B
$5.65M 0.71%
59,995
+1,935
+3% +$190K
TDC icon
44
Teradata
TDC
$3.02B
$5.32M 0.67%
143,757
-42,922
-23% -$1.77M
PCL
45
DELISTED
PLUM CREEK TIMBER CO (REIT)
PCL
$5.28M 0.66%
130,163
-11,441
-8% -$480K
NEE icon
46
NextEra Energy
NEE
$181B
$5.21M 0.66%
212,800
-5,084
-2% -$129K
PM icon
47
Philip Morris
PM
$292B
$5.14M 0.65%
64,067
-2,755
-4% -$227K
VEA icon
48
Vanguard FTSE Developed Markets ETF
VEA
$230B
$5.11M 0.64%
128,894
+13,350
+12% +$552K
ABT icon
49
Abbott
ABT
$185B
$5.05M 0.64%
102,936
-634
-0.6% -$30.4K
CVS icon
50
CVS Health
CVS
$134B
$4.84M 0.61%
46,184
+119
+0.3% +$12.2K

Similar funds

Boston Family Office's Q2 2015 Portfolio in Review

As of Q2 2015, Boston Family Office held 266 positions worth $796M, down 1.2% from $805M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Boston Family Office's Q2 2015 filing shows 7 new, 60 increased, 128 reduced and 11 closed positions. Its largest new stake was Avient: 16,501 shares worth $646K. The largest sale was Teradata, an estimated $1.77M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Industrials and Technology.

  • Boston Family Office's largest Q2 2015 buy was Avient: 16,501 shares worth $646K.
  • Boston Family Office added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.35M increase.
  • Boston Family Office's biggest Q2 2015 reduction was Teradata, cutting an estimated $1.77M.
  • Boston Family Office fully exited Costco in Q2 2015, selling an estimated $495K.
  • Boston Family Office's ten largest holdings make up 22% of its $796M portfolio in Q2 2015.
  • Boston Family Office opened 7 new positions and closed 11 in Q2 2015.
  • Boston Family Office's portfolio value fell 1.2% quarter-over-quarter to $796M.

Based on Boston Family Office's 13F filing for Q2 2015, filed 7 Aug 2015.